Miltenyi Biomedicine GmbH
Overview
Miltenyi Biomedicine develops and advances CAR-T therapies for oncology and autoimmune disorders, focusing on clinical programs and manufacturing technology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Miltenyi Biomedicine GmbH in our records. PharmaTek screens the full directory against live FDA enforcement data.
Verified Supplier Partner
Is this Miltenyi Biomedicine GmbH? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.